Fibro-osseous pseudotumor of digits and myositis ossificans show consistent COL1A1-USP6 rearrangement: a clinicopathological and genetic study of 27 cases.
Adult
Bone Diseases
/ genetics
Child
Child, Preschool
Collagen Type I
/ genetics
Collagen Type I, alpha 1 Chain
Diagnosis, Differential
Extremities
Fasciitis
/ genetics
Female
Fibroblasts
/ pathology
Gene Rearrangement
/ genetics
High-Throughput Nucleotide Sequencing
Humans
Male
Middle Aged
Musculoskeletal Diseases
/ genetics
Myositis Ossificans
/ genetics
Ubiquitin Thiolesterase
/ genetics
COL1A1
Fibro-osseous pseudotumor of digits
Genetics
Myositis ossificans
USP6
Journal
Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
18
09
2018
revised:
05
12
2018
accepted:
04
02
2019
pubmed:
5
4
2019
medline:
15
5
2020
entrez:
5
4
2019
Statut:
ppublish
Résumé
Myositis ossificans (MO) and fibro-osseous pseudotumor of digits (FOPD) are localized, self-limiting bone-producing pseudosarcomatous lesions characterized by nodular fasciitis-like proliferation and osteoid and immature woven bone production, which may eventually develop into more mature lamellar bone. Traditionally, MO and FOPD were thought to be of reactive, non-neoplastic nature. USP6 gene rearrangement was recently reported as a consistent finding in MO and FOPD, thus expanding the spectrum of transient, USP6-rearranged neoplasms. COL1A1 was described as the fusion partner of USP6 in a subset of MO cases, but the fusion partners of USP6-rearranged FOPD have not been uncovered so far. Initially, we carefully reviewed all 27 cases of MO/FOPD from our archives, documenting the remarkable morphological overlap between both lesions. Sixteen cases were seen in consultation, and our review was requested to rule in or rule out tentative diagnoses by referring pathologists. Malignant diagnosis (osteosarcoma) was suggested by the submitting pathologists in 3 cases, whereas 7 cases were sent by the referring pathologists to "rule out sarcoma." In the following step, using next-generation sequencing, we confirmed the COL1A1-USP6 rearrangement in 5/7 cases of MO and found the same abnormality in 4/5 of FOPD. Overall, 9 of the 12 analyzable cases (75%) of MO and FOPD harbored this gene fusion. The presence of COL1A1-USP6 gene rearrangement in MO/FOPD links these lesions to other USP6-driven tumors and represents a very useful supportive marker, which may help to avoid overdiagnosis of MO/FOPD as a sarcoma.
Identifiants
pubmed: 30946936
pii: S0046-8177(19)30053-X
doi: 10.1016/j.humpath.2019.02.009
pii:
doi:
Substances chimiques
Collagen Type I
0
Collagen Type I, alpha 1 Chain
0
USP6 protein, human
EC 3.4.19.12
Ubiquitin Thiolesterase
EC 3.4.19.12
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
39-47Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.